(Q39665543)

13 September 2017

title

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance (English)

1 reference

head and neck squamous cell carcinoma

13 September 2017

main subject

1 reference

8

Guoqing Hu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724142

19 June 2024

author name string

Yong Liu

1

1 reference

13 September 2017

Congliang Xie

2

1 reference

13 September 2017

Xin Zhang

3

1 reference

13 September 2017

Donghai Huang

4

1 reference

13 September 2017

Xiaojuan Zhou

5

1 reference

13 September 2017

Pingqing Tan

6

1 reference

13 September 2017

Lin Qi

7

1 reference

13 September 2017

Yongquan Tian

9

1 reference

13 September 2017

Yuanzheng Qiu

10

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20724142

19 June 2024

publication date

17 August 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0959804910006945?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

https://api.elsevier.com/content/article/PII:S0959804910006945?httpAccept=text/plain

19 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

European Journal of Cancer

19 June 2024

published in

1 reference

13 September 2017

volume

46

1 reference

13 September 2017

issue

16

1 reference

13 September 2017

page(s)

3007-3015

1 reference

13 September 2017

cites work

Cancer statistics, 2008

1

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Lymph node prognostic factors in head and neck squamous cell carcinomas

19 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays

19 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia

19 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Accessibility of nucleosomal DNA to V(D)J cleavage is modulated by RSS positioning and HMG1.

19 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal

19 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

19 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

19 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation

19 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

19 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer

19 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.

19 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma

19 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule

19 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy

19 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

19 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line

19 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases

19 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

High-mobility group box 1 and cancer

19 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Immunogenic cell death modalities and their impact on cancer treatment

19 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.

19 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter

19 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

HMGB1 interacts differentially with members of the Rel family of transcription factors

19 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway

19 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation

19 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

19 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

The inflammatory tumor microenvironment and its impact on cancer development

19 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Clinical proteomics and biomarker discovery.

19 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer

19 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

19 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.016

19 June 2024

Identifiers

1 reference

13 September 2017

1 reference